Novel physiologic functions of endocannabinoids as revealed through the use of mutant mice

Neurochemical Research

Volumn 26, Issue 8-9, 2001, Pages 1015-1021

  Kunos, George ^a   Btákai, Sándor ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

2 arachidonoyl glycerol; Anandamide; Cannabinoid receptors

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID; CANNABINOID RECEPTOR; CANNABIS; ENDOCANNABINOID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HELPER CELL; HIPPOCAMPUS; LONG TERM POTENTIATION; MOUSE; MUTANT; NONHUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; RECEPTOR GENE; SYNAPTIC INHIBITION; T LYMPHOCYTE ACTIVATION;

ANIMALS; CANNABINOIDS; ENDOCANNABINOIDS; MICE; MICE, MUTANT STRAINS; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0034764944     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012301021419     Document Type: Article

References (66)

1. Marihuana
2. Isolation, structure, and partial synthesis of an active constituent of hashish
3. Determination and characterization of a cannabinoid receptor in rat brain
4. Structure of a cannabinoid receptor and functional expression of the cloned cDNA
5. Cannabinoid receptor localization in brain
6. Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves
7. Molecular characterization of a peripheral receptor for cannabinoids
8. 2+-dependent release from rat brain of cannabinoid receptor binding activity
9. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
10. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
11. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory action
12. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes
13. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
14. Molecular characterization of an enzyme that degrades neuromodulatory fatty acids
15. Functional role of a high-affinity anandamide transport, as revealed by selective inhibition
16. 2-Arachidonoylglycerol: A possible endogenous cannabinoid ligand in brain
17. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
18. 2-Arachidonoylglycerol and cannabinoid receptors
19. Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand
20. Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice
21. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor
22. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses
23. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
24. SR144528, the first potent and selective antagonist of the CB2 cannabinoid receptor
25. Binding of non-classical cannabinoid CP 55,940 and the diazylpyrazole AM251 to rodent brain cannabinoid receptors
26. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation
27. Cannabinoid receptor interactions with the antagonists SR141716A and SR144528
28. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor. 1. Evidence for a new model of receptor/ligand interactions
29. The actions of the cannabinoid receptor antagonist, SR141716A, in the rat isolated mesenteric artery
30. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice
31. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
32. Cannabinoid-induced hypotension and bradycardia in rats is mediated by CB1-like cannabinoid receptors
33. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations
34. Enhanced long-term potentiation in mice lacking cannabinoid CB1 receptors
35. Enhancement of memory in cannabinoid CB1 receptor knock-out mice
36. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats
37. Lack of dopamine release in the nucleus accumbens of cannabinoid CB1 receptor knockout mice
38. Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse
39. Control of pain initiation by endogenous cannabinoids
40. Altered gene expression in striatal projection neurons in CB1 cannabinoid receptor knockout mice
41. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors
42. Cardiovascular effect of endocannabinoids - The plot thickens
43. A cannabinoid with cardiovascular activity but no overt behavioral effects
44. Mesenteric vasodilation mediated by endothelial anandamide receptors
45. The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication
46. Endocannabinoids: A novel class of vasoactive substances
47. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
48. Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: Evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain
49. Assessment of anandamide interaction with the cannabinoid brain receptor: SR141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain
50. Leptin-regulated endocannainoids are involved in maintaining food intake
51. Anandamide induces overeating: Mediation by central cannabinoid (CB1) receptors
52. Low dose anandamide affects food intake, cognitive function, neurotransmitter and corticosterone levels in diet-restricted mice
53. Appetite suppression and weight loss after the cannabinoid antagonist SR141716A
54. SR141716A, a CB1 cannabinoid receptor antagonist, selectively reduces sweet food intake in marmoset
55. Effects of SR141716A, a central cannabinoid receptor antagonist, on food-maintained responding
56. Central nervous system control of food intake
57. Leptin and the regulation of body weight in mammals
58. Leptin increases hypothalamic pro-opiomelanocortin mRNA expression in the rostral arcuate nucleus
59. The role of neuropeptide Y in the antiobesity action of the obese gene product
60. A hunger for endocannabinoids
61. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
62. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
63. Sensitivity to leptin and susceptibility to seizures in mice lacking neuropeptide Y
64. Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor
65. Delta-9-tetrahydrocannabinol modulates antigen processing by macrophages
66. Presynaptic specificity of endocannabinoid signaling in the hippocampus